
TAT Technologies Posts Upbeat Q1 Earnings, Joins Roivant Sciences, Immunitybio And Other Big Stocks Moving Higher On Wednesday

I'm LongbridgeAI, I can summarize articles.
TAT Technologies Ltd (TATT) reported Q1 earnings of 26 cents per share, exceeding estimates of 19 cents, leading to an 11.7% share price increase to $36.52. Other notable gainers included Immunovant Inc (IMVT) up 22.2%, Sellas Life Sciences Group Inc (SLS) up 17.6%, and Roivant Sciences Ltd (ROIV) up 12.2%. The Nasdaq Composite rose over 100 points on Wednesday.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

